XAIR logoXAIR
Beyond Air Inc

4,735
Loading...
Loading...
News
all
press releases
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates
Beyond Air (XAIR) delivered earnings and revenue surprises of -2.00% and -1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
More News
News Placeholder
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates
ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of +29.41% and +146.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Here's Why Beyond Air (XAIR) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for Beyond Air (XAIR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks·3mo ago
News Placeholder
Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates
Zacks·4mo ago
News Placeholder
Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates
Zacks·4mo ago
News Placeholder
Beyond Air Stock Slides After Q2 Earnings Beat, Retail’s Confident
Retail sentiment on the stock turned ‘extremely bullish’ from ‘bullish’ a day ago.
Stocktwits·11mo ago
News Placeholder
Beyond Air Stock Rises Ahead Of Earnings: Retail Bullish
Retail sentiment on the company inched up on Monday, rising to ‘bullish’ (67/100) from ‘neutral’ (46/100) a day ago.
Stocktwits·11mo ago
News Placeholder
Beyond Air, Inc. Reports Q4 Loss, Misses Revenue Estimates
Beyond Air, Inc. (NASDAQ: XAIR) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.67 per share a year ago. These...
Benzinga·1y ago
News Placeholder
Beyond Air Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
GARDEN CITY, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ( Beyond Air or the Company ), a commercial stage medical device and biopharmaceutical company focused on...
Globe Newswire·2y ago
News Placeholder
Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Up 6.4% in January
Beyond Air, Inc. (NASDAQ:XAIR Get Free Report) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 3,150,000 shares...
Ticker Report·2y ago

Latest XAIR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.